Osteonecrosis Clinical Trial
Official title:
A Comparison of Two Different Surgical Techniques to Preserve the Bony Supply and Improve Implant Longevity in Hip Resurfacing Arthroplasty
The purpose of the study is to compare two different surgical techniques in hip resurfacing arthroplasty (RHA), comparing bloodflow and metabolism in the femoral head, as well as implant migration, periprosthetic bone mineral density, gait function and patient recovery.
BACKGROUND: 6700 total hip replacements are performed each year in Denmark due to osteoarthritis. Young patients sustain a substantial risk of early implant failure due to high-activity daily living, and among patients younger than 55 years at surgery 20 percent need revision surgery within ten years. Revision surgery is more complicated than primary surgery and associated with decreased implant longevity due to decreased bone stock. Resurfacing hip arthroplasty (RHA), restores the anatomy of the hip as only the articulating joint surfaces are replaced, and thus more bone is left to ensure a better opportunity of successful revision surgery later on. The clinical midterm evaluation of RHA survival is promising, but two major complications leading to early revision, namely osteonecrosis and femoral neck fracture, has raised concern regarding the influence of surgical technique on the vascularity of the femoral head. RHA is commonly performed through a posterolateral surgical approach. By this technique muscle tendons are spilt resulting in decreased patient mobility for several weeks after surgery, but more importantly, the blood supply is compromised as a large artery has to be ligated. This is speculated to decrease the blood supply to femoral head and neck and thereby increase the risk of osteonecrosis, femoral neck fracture, and implant failure. With a new surgical technique facilitating an anterolateral approach to the hip joint the blood supply is left intact as well as the muscle tendons. HYPOTHESIS: An anterolateral surgical approach in resurfacing hip arthroplasty will 1) preserve the blood supply to the femoral head and neck and improve implant longevity, and 2) spare the muscle tendons and ease patient recovery. METHOD and FACILITIES: 50 patients, aged 30 to 60 years, with osteoarthrosis of the hip will be randomised to a RHA inserted by either an anterolateral or a posterolateral surgical approach. Primary points of evaluation are 1) blood supply to the femoral head and neck measured intraoperatively by Laser Doppler flowmetry and postoperatively by microdialysis established during surgery. Secondary points of evaluation are 1) implant fixation measured by radiostereometric analysis (RSA), and 2) periprosthetic bone mineral density (BMD) measured by dual energy x-ray absorptiometry (DEXA), 3) gait analysis and 4) clinical scores of function, pain and activities of daily living (Harris Hip Score , Visual Analogue Scale). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04072055 -
MOTO Post-marketing Surveillance Study
|
||
Terminated |
NCT02941666 -
Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip
|
||
Terminated |
NCT01763684 -
Oxford Signature vs. Conventional Global Study
|
N/A | |
Completed |
NCT00505219 -
Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head
|
Phase 3 | |
Withdrawn |
NCT02632903 -
Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study
|
Phase 2 | |
Active, not recruiting |
NCT01458782 -
ACI-C Versus AMIC. A Randomized Trial Comparing Two Methods for Repair of Cartilage Defects in the Knee
|
N/A | |
Completed |
NCT01583465 -
Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty
|
N/A | |
Active, not recruiting |
NCT04401267 -
Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma
|
Phase 2 | |
Completed |
NCT03197623 -
Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids
|
Phase 1 | |
Active, not recruiting |
NCT05283148 -
Sickle Cell Disease (SCD) Bone Pain Study
|
N/A | |
Completed |
NCT05684588 -
Post-COVID-19 Sequelae: Osteonecrosis of Femoral Head
|
N/A | |
Terminated |
NCT03269409 -
Use of Adipose Derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis
|
Phase 1 | |
Enrolling by invitation |
NCT02893293 -
Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI
|
Phase 4 | |
Completed |
NCT01345097 -
A Short Metaphyseal Fitting Total Hip Arthroplasty in Young and Elderly Patients
|
Phase 4 | |
Recruiting |
NCT00260897 -
Molecular Genetic Study of Avascular Necrosis of the Femoral Head
|
N/A | |
Not yet recruiting |
NCT06016634 -
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
|
Phase 2 | |
Completed |
NCT02077647 -
Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee
|
||
Recruiting |
NCT01619124 -
Osteonecroses in Pediatric Patients With ALL
|
N/A | |
Completed |
NCT02458937 -
Functional Outcomes Following Hip Core Decompression in Younger Participants With Osteonecrosis
|
||
Recruiting |
NCT02661139 -
Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction
|